In 2022, the Global Mucopolysaccharidosis (MPS) Treatment Industry is anticipated to be worth roughly US$2.38 billion. The total market is anticipated to develop at a strong CAGR of 5.9% between 2022 and 2029, reaching a valuation of US$ 3.37 Billion by 2029 due to the rising prevalence of mucopolysaccharidosis (MSP) globally. According to research, the mucopolysaccharidosis treatment …
Tag Archives: Mucopolysaccharidosis (MPS) Treatment
Global Mucopolysaccharidosis (MPS) Treatment Industry Set to Reach US$ 3.37 Billion by 2029, Reports Future Market Insights
The Global Mucopolysaccharidosis (MPS) Treatment Industry is poised for significant growth, with a projected valuation of US$ 3.37 billion by 2029, as stated in a comprehensive market study presented by Future Market Insights (FMI). In 2022, the market is estimated to be worth approximately US$2.38 billion, showcasing a strong Compound Annual Growth Rate (CAGR) of …